1Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type dis- tribution in invasive cervical cancer and high-grade cervical lesions : a meta-analysis update [J]. Int J Cancer, 2007,121 (3) : 621 - 632.
2Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis[J]. Br J Cancer,2003,88 (1) :63 - 73.
3Bekkers RL, Massuger LF, Bulten J, et al. Epidemiological and clin- ical aspects of human papiUomavirus detection in the prevention of cervical cancer[J]. Rev Med Viral,2004,14 (2) :95 - 105.
4Hopman AH, Smedts F, Dignef W, et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromo- some abnormalities[J]. J Pathol,2004, 202(1) :23 -33.
5Alvarez-Salas LM, DiPaolo JA. Molecular approaches to cervical cancer therapy J . Curr Drug Discov Technol, 2007,4 (3) : 208-219.
6Einstein MH, Schiller JT, Viscidi RP, et al. Clinician's guide to hu- man papillomavirus immunology: knowns and unknowns [J]. Lancet Infect Dis,2009,9 (6) :347 - 356.
7Caberg JH, Hubert PM, Begon DY, et al. Silencing of E7 oncogene restoresfunetional E-cadherin expression in human papillomavinas 16-transformed keratinocytes [J]. Carcinogenesis, 2008,29 7) : 1441-1447.
8Johung K, GcxMwin EC, DiMaio D. Human papillomavirus E7 re- pression in cervical carcinoma cells initiates a transcriptional cas- cade driven by the retinoblastoma family, resulting in senescence [J]. J Virol,2007,81 (5):2102 -2116.
9Castellsagu6 X. Natural history and epidemiology of HPV infection and cervical cancer[J]- Gynecol Oncol, 200g, 110 ( 3 Suppl 2 ) : S4-7.
10Oh JM, Kim SH,Cho EA,et al. Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells [J]. Carcinogenesis, 2010,31 (3) :402 - 410.
8Sandri MT,Lentati P,Benini E. Compari-son of the Digene HC2 as-say and the Roche AMPLICOR human papillsmariras(HPV) test for de-tection of hig-risk HPV genotypes in cervical samples[J].J Clin Microbi-ol,2006,(16):2141-2146.
